Glaxo Wellcome S.A.
PolandAll medications by this manufacturer
-
Adartrel
Form: tablets, film-coated
Active substance Dosage ropinirole 0,250 mg ATC: N04BC04
-
Adartrel
Form: tablets, film-coated
Active substance Dosage ropinirole 0,50 mg ATC: N04BC04
-
Adartrel
Form: tablets, film-coated
Active substance Dosage ropinirole 2.00 g ATC: N04BC04
-
Flixonase
Form: spray, nasal suspension
Active substance Dosage fluticasone propionate 0.05 g ATC: R01AD08
-
Lacipil
Form: tablets, film-coated
Active substance Dosage lacidipine 6 mg ATC: C08CA09
-
Requip
Form: tablets, film-coated
Active substance Dosage ropinirole hydrochloride 2 mg ATC: N04BC04
-
Requip
Form: tablets, film-coated
Active substance Dosage ropinirole hydrochloride 0.5 mg ATC: N04BC04
-
Requip
Form: tablets, film-coated
Active substance Dosage ropinirole hydrochloride 5 mg ATC: N04BC04
-
Requip
Form: tablets, film-coated
Active substance Dosage ropinirole hydrochloride 0.25 mg ATC: N04BC04
-
Requip
Form: tablets, film-coated
Active substance Dosage ropinirole hydrochloride 1 mg ATC: N04BC04
-
Requip modutab
Form: tablets, prolonged release
Active substance Dosage ropinirole hydrochloride 4 mg ATC: N04BC04
-
Requip modutab
Form: tablets, prolonged release
Active substance Dosage ropinirole hydrochloride 8 mg ATC: N04BC04
-
Requip modutab
Form: tablets, prolonged release
Active substance Dosage ropinirole hydrochloride 2 mg ATC: N04BC04
-
Zyban
Form: tablets, film-coated, prolonged release
Active substance Dosage bupropion hydrochloride 150 mg ATC: N06AX12